SEOM clinical guidelines in gestational trophoblastic disease (2017)

被引：0
作者：
A. Santaballa
Y. García
A. Herrero
N. Laínez
J. Fuentes
A. De Juan
V. Rodriguez Freixinós
J. Aparicio
A. Casado
E. García-Martinez
机构：
[1] Hospital Universitari i Politècnic La Fe,Servicio de Oncología Médica
[2] Corporació Sanitària Parc Taulí,Servicio de Oncología Médica
[3] Hospital Miguel Servet,Servicio de Oncología Médica
[4] Complejo Hospitalario de Navarra,Servicio de Oncología Médica
[5] Hospital Nuestra Señora de Valme,Servicio de Oncología Médica
[6] Hospital Universitario Marqués de Valdecilla,Servicio de Oncología Médica
[7] Hospital Universitario Vall d´Hebrón,Servicio de Oncología Médica
[8] Hospital Clínico Universitario San Carlos,Servicio de Oncología Médica
[9] Hospital Universitario Morales Meseguer,Servicio de Oncología Médica
来源：
Clinical and Translational Oncology | 2018年 / 20卷
关键词：
Gestational trophoblastic disease; Gestational trophoblastic neoplasia; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidence-based recommendation on how to manage GTD.
引用
收藏
页码：38 / 46
页数：8
相关论文
共 111 条
  • [1] Brown J(2017)15 years of progress in gestational trophoblastic disease: scoring, standardization, and salvage Gynecol Oncol 144 200-207
  • [2] Naumann RW(2003)Gestational trophoblastic disease epidemiology and trends Clin Obstet Gynecol 46 541-556
  • [3] Seckl MJ(2010)Immunohistochemical staining for diagnosis and prognostic assessment of hydatidiform moles: current evidence and future directions J Reprod Med 55 236-246
  • [4] Schink J(2012)The genetics of gestational trophoblastic disease: a rare complication of pregnancy Cancer Genet 205 63-77
  • [5] Smith HO(2009)Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study Lancet 374 48-55
  • [6] Sebire NJ(2012)Gestatational trophoblastic disease: multimodality imaging assessment with special emphasis on spectrum of abnormalities and value of imaging in staging and management of disease Curr Probl Diagn Radiol 41 1-10
  • [7] Seckl MJ(2013)Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 vi39-vi50
  • [8] Hoffner L(2002)FIGO staging for gestational trophoblastic neoplasia 2000. FIGO Oncology Committee Int J Gynaecol Obstet 77 285-287
  • [9] Surti U(2013)Role of 18-FDG-PET in the management of gestational trophoblastic neoplasia Eur J Nucl Med Mol Imaging 40 505-513
  • [10] Schmid P(2012)Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia Br J Cancer 106 1089-1094
12345678910